Tirzepatide is a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://miriamotji613004.free-blogz.com/88051900/tirzepatide-a-new-frontier-in-diabetes-treatment